|Articles|January 2, 2019

FROM PRMA CONSULTING

Drive payer submission readiness for your Phase 2 and 3 products

Newsletter

Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.

Subscribe

Related Content

Independent Pharmacy's Evolving Role: Michelle Britt on What's Next

ByMichelle Britt,Stephen Appezzato

August 24th 2026

Adam Colborn, vice president, government affairs, AMCP.

Q&A: Why Managed Care Still Doubts TrumpRx's Savings Claims

ByAdam Colborn, JD,Stephen Appezzato

August 24th 2026

When PV Infrastructure Fails, Commercial Launches Pay the Price

ByVikram Anand,Stephen Appezzato

August 21st 2026

Will PBMs' TrumpRx Price Pledge Reach Prescribers?

ByStephen Appezzato

August 21st 2026

Person delivering pharmacy medication package to front door step | © PECHA - stock.adobe.com 1907837269

Report: Mail-Order Pharmacy Satisfaction Climbs as Retail Trust Slips

ByStephen Appezzato

August 20th 2026

FROM PRMA CONSULTING

Related Content

Independent Pharmacy's Evolving Role: Michelle Britt on What's Next

Q&A: Why Managed Care Still Doubts TrumpRx's Savings Claims

When PV Infrastructure Fails, Commercial Launches Pay the Price

Will PBMs' TrumpRx Price Pledge Reach Prescribers?

Report: Mail-Order Pharmacy Satisfaction Climbs as Retail Trust Slips

Trending on Pharmaceutical Commerce

Will PBMs' TrumpRx Price Pledge Reach Prescribers?

Q&A: Why Managed Care Still Doubts TrumpRx's Savings Claims

Independent Pharmacy's Evolving Role: Michelle Britt on What's Next

Pharma Pulse: Overton's FDA Bid, EVERSANA's AI Expansion, and a Landmark Cancer Vaccine

Michelle Britt on the Three Forces Reshaping Independent Pharmacy Economics